DOR BioPharma Reports Third Quarter Financial Results, Reviews Recent Achievements
15th Nov 2006, 03:53 GMT
DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company") today announced financial results for the third quarter ended September...
DOR BioPharma Reports Third Quarter Financial Results, Reviews Recent Achievements related news:
- DOR BioPharma, Inc.: DOR BioPharma Reports Third Quarter Financial Results, Reviews Recent Achievements — Market Wire - Medical and Healthcare
- Adherex Reports Third Quarter 2006 Financial Results — ArriveNet : Press Releases
- Jaclyn Reports First Quarter Financial Results; Announces Developments Concerning Purchase Option on West New York Facility — ArriveNet : Press Releases
- Novacea Reports Third Quarter 2006 Financial Results — ArriveNet : Press Releases
- BioSante Pharmaceuticals Reports Third Quarter 2006 Financial Results — NSTI nanoPRwire
- Novacea: Novacea Reports Third Quarter 2006 Financial Results — Market Wire - Earnings Reports
- Catalytica Energy Systems, Inc.: Catalytica Energy Systems Reports Third Quarter Financial Results — Market Wire - Energy and Utilities
- Miramar Mining Reports Financial Results for Third Quarter 2006 — ArriveNet : Business
- Vector Group Reports Third Quarter 2006 Financial Results — Nachrichten Ticker - www.finanzen.net
- SpaceDev Reports Third Quarter Fiscal 2006 Results — ArriveNet : Travel
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- PuriCore Plc announces Appointment
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL